Search

Recurium IP Holdings WEE1 Inhibitor Patent

The USPTO granted Patent US12606567B2 to Recurium IP Holdings, LLC on April 21, 2026, covering salts and forms of WEE1 inhibitor Compound A, including adipate salt Form A. The patent discloses pharmaceutical applications for treating diseases characterized by excessive cellular proliferation, including breast cancer. The patent contains 23 claims under CPC classifications C07D 487/04 and C07B 2200/13.